Home » 2006 » Volume 8 - Number 3 » Is There Any Risk of Intracranial Hemorrhage Using Tipranavir?
Ivana Maida
NULL
*Correspondence: Ivana Maida, Email not available
Is There Any Risk of Intracranial Hemorrhage Using Tipranavir?
Ritonavir-boosted tipranavir is indicated for antiretroviraltreatment of adult patients infected with HIV-1 with evidence of viral replication and who aretreatment-experienced or have HIV-1 strains resistantto protease inhibitors.